Tech Company Financing Transactions
Venclose Funding Round
Venclose, based in San Jose, received $27 million in investment from Ally Bridge Group and private investors.
Transaction Overview
Company Name
Announced On
12/4/2019
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series C
Investors
Ally Bridge Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate its commercial footprint in the US, expand globally, and invest in selective product portfolio additions.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2570 N. 1st St. 2nd Floor 221
San Jose, CA 95131
USA
San Jose, CA 95131
USA
Phone
Website
Email Address
Overview
We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of adults. To improve the physician and patient experience during chronic venous insufficiency treatment by commercializing the next-generation RF therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jerry Gibson
Chief Financial Officer
Peter Osborne
Chief Medical Officer
Jeffrey Carr
Chief Operating Officer
Jason Turner
VP - R & D
Michael Mirizzi
VP - Sales
Dieter Bielang
VP - Sales
Gary McCord
Browse more venture capital transactions:
Prev: 12/4/2019: Dolls Kill venture capital transaction
Next: 12/4/2019: Impulse Dynamics venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs